Valiant Laboratories Board approves exploring restructuring among group entities to achieve operational and strategic synergies.
Strategic objectives include unlocking shareholder value, creating aligned business platforms, and enhancing operational efficiency.
Restructuring may involve amalgamation, merger, demerger or reorganization through multiple transactions subject to approvals.
Company will make further disclosures as evaluation progresses and Board determines appropriate course of action.